Authors: Zaunders, JJ Kaufmann, GR Cunningham, PH Smith, D Grey, P Suzuki, K Carr, A Goh, LE Cooper, DA

Citation: Jj. Zaunders et al., Increased turnover of CCR5(+) and redistribution of CCR5(-) CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection, J INFEC DIS, 183(5), 2001, pp. 736-743

Authors: Cunningham, PH Smith, DG Satchell, C Cooper, DA Brew, B

Citation: Ph. Cunningham et al., Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid, AIDS, 14(13), 2000, pp. 1949-1954

Authors: Cunningham, PH LeClair, DT Murphy, PE

Citation: Ph. Cunningham et al., Untitled - Introduction, J BUS ETHIC, 23(3), 2000, pp. 235-235

Authors: MacDonald, MA Wodak, AD Dolan, KA van Beek, I Cunningham, PH Kaldor, JM

Citation: Ma. Macdonald et al., Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997, MED J AUST, 172(2), 2000, pp. 57-61

Authors: Zaunders, JJ Cunningham, PH Kaufmann, GR Cooper, DA

Citation: Jj. Zaunders et al., Questions about results reported with potent antiretroviral therapy for human immunodeficiency virus type 1 infection - Reply, J INFEC DIS, 181(4), 2000, pp. 1519-1520

Authors: Zaunders, JJ Cunningham, PH Kelleher, AD Kaufmann, GR Jaramillo, AB Wright, R Smith, D Grey, P Vizzard, J Carr, A Cooper, DA

Citation: Jj. Zaunders et al., Potent antiretroviral therapy of primary human immunodeficiency virus type1 (HIV-1) infection: Partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia, J INFEC DIS, 180(2), 1999, pp. 320-329